Appointment booking for Dr. Christopher Sciamanna, DO is currently not available.Dr. Christopher Sciamanna, DO has not yet fully activated their profile on DiabetesIQ.
Dr. Christopher Sciamanna, DO (he/him) is a Cardiologist, Advanced Heart Failure and Transplant Cardiologist, Internist in Oak Lawn, IL with over 13 years of experience. What is your opinion of Dr. Christopher Sciamanna, DO? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 13 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Christopher Sciamanna, DO has received over $5,055 which includes payments from the following companies:
$2,774.31 from Abbott Laboratories
$1,560.01 from Medtronic Vascular, Inc.
$131.84 from Pfizer Inc.
$107.07 from Novartis Pharmaceuticals Corporation
$98.57 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$98.13 from AbbVie, Inc.
$90.97 from Boston Scientific Corporation
$49.67 from Lantheus Medical Imaging, Inc.
$45.00 from BIOTRONIK INC.
$19.06 from Maquet Cardiovascular U.S. Sales, L.L.C.
$17.12 from Janssen Pharmaceuticals, Inc
$17.08 from Sunshine Heart Inc
$16.35 from Vascular Solutions, Inc.
$15.30 from AstraZeneca Pharmaceuticals LP
$15.00 from Teleflex LLC
Payments received by Dr. Christopher Sciamanna, DO were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!